RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Research & development

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Jun 30, 2025331+7.73%
Jun 30, 2024308+6.91%
Jun 30, 2023288+13.43%
Jun 30, 2022254+12.56%
Jun 30, 2021225+11.56%
Jun 30, 2020202+11.79%
Jun 30, 2019181+16.44%
Jun 30, 2018155+7.39%
Jun 30, 2017144+21.76%
Jun 30, 2016119+3.30%
Jun 30, 2015115-2.84%
Jun 30, 2014118-1.58%
Jun 30, 2013120+9.47%
Jun 30, 2012110+19.27%
Jun 30, 201192

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)